PRUDENTIAL LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Prudential Financial, Inc. – PRU
December 08, 2019 13:48 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Prudential...
REAL LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds The RealReal, Inc. Investors of Important Deadline in Securities Class Action First Filed by the Firm – REAL
December 08, 2019 13:00 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of The RealReal, Inc. (NASDAQ: REAL) pursuant and/or traceable to...
Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
December 08, 2019 12:00 ET
|
Kura Oncology, Inc.
– Tipifarnib demonstrates robust and durable activity as a monotherapy in advanced AITL, an aggressive form of T-cell lymphoma – – Enhanced activity (40% CR rate, 70% ORR) observed in AITL patients...
IROBOT LOSS ALERT: ROSEN LAW FIRM Reminds iRobot Corporation Investors of Important December 23rd Deadline in Securities Class Action - IRBT
December 08, 2019 11:50 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of iRobot Corporation (NASDAQ: IRBT) between November 21, 2016 and...
SEE LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds Sealed Air Corporation Investors of Important Deadline in Securities Class Action – SEE
December 08, 2019 11:00 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sealed Air Corporation (NYSE: SEE) between November 5, 2014 and...
Fate Therapeutics Announces New Preclinical Data for FT596 Off-the-Shelf, iPSC-derived CAR NK Cell Cancer Immunotherapy
December 08, 2019 10:39 ET
|
Fate Therapeutics, Inc.
FT596 as a Monotherapy Demonstrates Comparable Anti-tumor Activity to CAR19 T Cells In Vivo in Humanized Mouse Model of Lymphoma Combination of FT596 with Rituximab Shows Durable Tumor Clearance In...
Seluxit signs an agreement with a new client within the healthcare industry
December 08, 2019 10:27 ET
|
Seluxit A/S
Company Announcement No. 17 Aalborg, 8. December 2019 Seluxit signs an agreement with a new client within in the healthcare industry Seluxit is pleased to announce an upcoming collaboration with a...
ENERGY TRANSFER LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Energy Transfer LP – ET
December 08, 2019 10:00 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Energy...
Autolus Therapeutics Announces New Data Showcasing Clinical Progress of AUTO3 in B Cell Malignancies
December 08, 2019 09:15 ET
|
Autolus Therapeutics plc
Preliminary data on AUTO3 in DLBCL demonstrate safety and feasibilty of CD19 and CD22 dual targeting CAR T 90% complete response and 100% overall survival at 12 months in CAR T naive pediatric ALL...
Innate Pharma highlights FDA-approved Lumoxiti® at ASH 2019
December 08, 2019 09:00 ET
|
INNATE PHARMA
Final analysis expands on efficacy results from pivotal Phase III trial of Lumoxiti in hairy cell leukemia; durable, complete responses maintained in long-term follow-up data Innate...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst